Fidelity SPDR Advertisement
Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Board Catalyst and Chart Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
Member Level 
Followed By 468
Posts 66,472
Boards Moderated 2
Alias Born 03/31/08
160x600 placeholder
U.S. Stocks End Lower; Tech And Small-caps Lead Losses
U.S. stocks closed mostly lower on Monday with losses led by technology and small-cap stocks as investors continued to unload riskier position ahead of this week's pivotal Federal Reserve policy meeting.
Top Equities Stories Of The Day
Tech Stocks Fall; Microsoft Among Decliners
Citigroup Releases Mid-Cycle 'Stress Test' Figures
U.S., EU Widen Sanctions on Russia
Blur Group Appoints Ex-Microsoft Executive as New CFO
Americans Support Striking Islamic Militants, Poll Shows
Sirius XM Increases 2014 Subscriber Guidance, Citing Strong Summer Car Sales
U.S. Livestock Futures Edge Lower; Cattle Extends Slump on Supplies
Hong Kong Stocks Continue Losing Streak After Weak Chinese Data
dDT Member Level  Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 81256 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist